Advanced company searchLink opens in new window

ST ANDREWS PHARMACEUTICAL TECHNOLOGY LTD

Company number 12551706

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
18 Aug 2024 AA Total exemption full accounts made up to 31 December 2023
13 Aug 2024 SH01 Statement of capital following an allotment of shares on 25 October 2021
  • GBP 106.25
21 May 2024 CS01 Confirmation statement made on 7 April 2024 with no updates
05 Oct 2023 AA Total exemption full accounts made up to 31 December 2022
13 May 2023 CS01 Confirmation statement made on 7 April 2023 with updates
05 Oct 2022 AA Total exemption full accounts made up to 31 December 2021
18 May 2022 PSC07 Cessation of Christopher Joseph Crabtree Taylor as a person with significant control on 1 October 2021
18 May 2022 CS01 Confirmation statement made on 7 April 2022 with updates
05 Oct 2021 AA Total exemption full accounts made up to 31 December 2020
31 May 2021 CS01 Confirmation statement made on 7 April 2021 with updates
04 Mar 2021 SH01 Statement of capital following an allotment of shares on 2 February 2021
  • GBP 102
07 Jan 2021 AA01 Previous accounting period shortened from 30 April 2021 to 31 December 2020
29 Oct 2020 CERTNM Company name changed zenotop LIMITED\certificate issued on 29/10/20
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2020-10-27
15 Aug 2020 SH02 Sub-division of shares on 29 April 2020
20 Jul 2020 MA Memorandum and Articles of Association
20 Jul 2020 RESOLUTIONS Resolutions
  • RES13 ‐ Sub division 29/04/2020
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
11 May 2020 PSC04 Change of details for Mr Christopher Joseph Crabtree Taylor as a person with significant control on 1 May 2020
07 May 2020 AP01 Appointment of Hazel Hutchinson as a director on 4 May 2020
07 May 2020 AP01 Appointment of Mr David Edey as a director on 4 May 2020
07 May 2020 PSC04 Change of details for Mr Christopher Taylor as a person with significant control on 1 May 2020
07 May 2020 PSC01 Notification of Christopher Taylor as a person with significant control on 1 May 2020
07 May 2020 PSC04 Change of details for Dr William John Henry as a person with significant control on 1 May 2020
07 May 2020 SH01 Statement of capital following an allotment of shares on 1 May 2020
  • GBP 100
07 May 2020 SH01 Statement of capital following an allotment of shares on 29 April 2020
  • GBP 27
08 Apr 2020 NEWINC Incorporation
Statement of capital on 2020-04-08
  • GBP 1